Shandong Weigao Group Medical Polymer Company Limited
SHWGF
$0.50
-$0.02-3.85%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.82B | 1.81B | 1.82B | 1.81B | 1.80B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.82B | 1.81B | 1.82B | 1.81B | 1.80B |
| Cost of Revenue | 919.40M | 913.45M | 910.81M | 908.03M | 903.45M |
| Gross Profit | 895.75M | 900.45M | 908.51M | 901.33M | 892.43M |
| SG&A Expenses | 504.17M | 503.95M | 505.56M | 514.88M | 523.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.51B | 1.51B | 1.50B | 1.51B | 1.51B |
| Operating Income | 302.97M | 308.88M | 316.02M | 301.37M | 286.21M |
| Income Before Tax | 334.50M | 344.08M | 354.97M | 334.82M | 314.08M |
| Income Tax Expenses | 48.13M | 51.14M | 54.35M | 47.66M | 40.90M |
| Earnings from Continuing Operations | 286.37 | 292.93 | 300.62 | 287.15 | 273.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -13.68M | -13.49M | -13.35M | -10.87M | -8.37M |
| Net Income | 272.69M | 279.44M | 287.26M | 276.28M | 264.81M |
| EBIT | 302.97M | 308.88M | 316.02M | 301.37M | 286.21M |
| EBITDA | 434.61M | 438.55M | 444.17M | 427.11M | 409.28M |
| EPS Basic | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Normalized Basic EPS | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 |
| EPS Diluted | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Normalized Diluted EPS | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 |
| Average Basic Shares Outstanding | 18.23B | 18.19B | 18.15B | 18.14B | 18.12B |
| Average Diluted Shares Outstanding | 18.23B | 18.30B | 18.26B | 18.24B | 18.22B |
| Dividend Per Share | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Payout Ratio | 44.49% | 43.41% | 42.23% | 40.37% | 38.26% |